CCPortal

浏览/检索结果: 共28条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Rich people are boiling the planet 科技资讯
2023
收藏  |  浏览/下载:5/0  |  提交时间:2023/10/20
Climate Change 2022: Mitigation of Climate Change 科技报告
, 2022
作者:  Jim Skea
JPEG(8Kb)  |  收藏  |  浏览/下载:138/33  |  提交时间:2022/04/06
Hamburg Climate Futures Outlook Assessing the Plausibility of Deep Decarbonization by 2050 科技报告
, 2021
作者:  [unavailable]
Adobe PDF(6832Kb)  |  收藏  |  浏览/下载:15/0  |  提交时间:2021/11/24
Progress in Adapting to Climate Change - 2021 Report to Parliament 科技报告
, 2021
作者:  [unavailable]
Adobe PDF(9065Kb)  |  收藏  |  浏览/下载:17/0  |  提交时间:2021/11/24
At last, a malaria vaccine has passed important clinical trials 科技资讯
2021
收藏  |  浏览/下载:18/0  |  提交时间:2021/05/12
New Zealand's Greenhouse Gas Inventory 1990-2019 科技报告
, 2021
作者:  [unavailable]
Adobe PDF(9763Kb)  |  收藏  |  浏览/下载:15/1  |  提交时间:2021/11/24
Reflecting Sunlight Recommendations for Solar Geoengineering Research and Research Governance 科技报告
, 2021
作者:  [unavailable]
Adobe PDF(6091Kb)  |  收藏  |  浏览/下载:14/0  |  提交时间:2021/11/24
Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination 期刊论文
Proceedings of the National Academy of Sciences of the United States of America, 2021, 卷号: 118, 期号: 28
作者:  Tscherne A.;  Hendrik Schwarz J.;  Rohde C.;  Kupke A.;  Kalodimou G.;  Limpinsel L.;  Okba N.M.A.;  Bošnjak B.;  Sandrock I.;  Odak I.;  Halwe S.;  Sauerhering L.;  Brosinski K.;  Liangliang N.;  Duell E.;  Jany S.;  Freudenstein A.;  Schmidt J.;  Werner A.;  Serra M.G.;  Klüver M.;  Guggemos W.;  Seilmaier M.;  Wendtner C.-M.;  Förster R.;  Haagmans B.L.;  Becker S.;  Sutter G.;  Volz A.
收藏  |  浏览/下载:41/0  |  提交时间:2021/11/25
Complete biosynthesis of the potential medicine icaritin by engineered Saccharomyces cerevisiae and Escherichia coli 期刊论文
Science Bulletin, 2021
作者:  Wang P.;  Li C.;  Li X.;  Huang W.;  Wang Y.;  Wang J.;  Zhang Y.;  Yang X.;  Yan X.;  Wang Y.;  Zhou Z.
收藏  |  浏览/下载:22/0  |  提交时间:2021/09/01
Efficacy and safety of chiglitazar, a novel peroxisome proliferator-activated receptor pan-agonist, in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, phase 3 trial (CMAP) 期刊论文
Science Bulletin, 2021, 卷号: 66, 期号: 15
作者:  Ji L.;  Song W.;  Fang H.;  Li W.;  Geng J.;  Wang Y.;  Guo L.;  Cai H.;  Yang T.;  Li H.;  Yang G.;  Li Q.;  Liu K.;  Li S.;  Liu Y.;  Shi F.;  Li X.;  Gao X.;  Tian H.;  Ji Q.;  Su Q.;  Zhou Z.;  Wang W.;  Zhou Z.;  Li X.;  Xu Y.;  Ning Z.;  Cao H.;  Pan D.;  Yao H.;  Lu X.;  Jia W.
收藏  |  浏览/下载:37/0  |  提交时间:2021/09/01
Carfloglitazar  Chiglitazar  Glycemic control  Insulin resistance  PPAR pan-agonist  Type 2 diabetes